>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Renews Request for Action from OIG on “Company Model”

Wednesday, June 16, 2010

ASA has submitted a letter to the Office of Inspector General (OIG) renewing its March 19, 2009, request for a Special Advisory Bulletin regarding the “company model.” A recent independent legal analysis published in the CCH Health Care Compliance Letter (reprinted with permission) supports ASA’s position that the “company model” potentially violates the Federal anti-kickback and self-referral provisions of the Social Security Act.

OIG "Company Model" Letter - June 16, 2010

« Back to Washington Alerts